Jubilant Ingrevia Q4 Revenue Rises 12 Per Cent
ECONOMY & POLICY

Jubilant Ingrevia Q4 Revenue Rises 12 Per Cent

Jubilant Ingrevia reported a healthy performance in Q4 FY26, with revenue rising 12 per cent year-on-year and EBITDA increasing 11 per cent year-on-year. The company said strong execution, resilient demand and effective handling of Middle East disruptions supported its quarterly performance.

The company highlighted that it faced no force majeure and recorded zero production loss during the Middle East crisis. It also achieved successful dispatch from its newly constructed Agro CDMO facility and completed the acquisition of Remidex to accelerate growth in its Human Nutrition business.

The Board recommended a final dividend of Rs 2.50 per share, taking the total FY26 dividend to Rs 5 per share. The company said demand across the chemical industry remains resilient, with volumes growing and pricing firming up due to higher crude-linked costs.

Pharmaceuticals continued to support growth through strong volumes and steady demand, while the agrochemicals business saw strong export visibility and price increases. Nutrition and Personal Care markets also grew, driven by Niacinamide and demand across Feed and Cosmetics.

For FY27, Jubilant Ingrevia expects growth to be led by Specialty Chemicals and Nutrition, supported by recovery in Acetyls. The company also said construction of its Gajraula Multi Purpose Plant is progressing well and will strengthen its CDMO growth roadmap.

Jubilant Ingrevia reported a healthy performance in Q4 FY26, with revenue rising 12 per cent year-on-year and EBITDA increasing 11 per cent year-on-year. The company said strong execution, resilient demand and effective handling of Middle East disruptions supported its quarterly performance.The company highlighted that it faced no force majeure and recorded zero production loss during the Middle East crisis. It also achieved successful dispatch from its newly constructed Agro CDMO facility and completed the acquisition of Remidex to accelerate growth in its Human Nutrition business.The Board recommended a final dividend of Rs 2.50 per share, taking the total FY26 dividend to Rs 5 per share. The company said demand across the chemical industry remains resilient, with volumes growing and pricing firming up due to higher crude-linked costs.Pharmaceuticals continued to support growth through strong volumes and steady demand, while the agrochemicals business saw strong export visibility and price increases. Nutrition and Personal Care markets also grew, driven by Niacinamide and demand across Feed and Cosmetics.For FY27, Jubilant Ingrevia expects growth to be led by Specialty Chemicals and Nutrition, supported by recovery in Acetyls. The company also said construction of its Gajraula Multi Purpose Plant is progressing well and will strengthen its CDMO growth roadmap.

Next Story
Technology

LTTS Partners with Databricks to Advance Industrial AI

L&T Technology Services (LTTS) has entered a strategic partnership with Databricks to co-develop Industrial AI solutions for asset-intensive industries, including energy, petrochemicals, and manufacturing. The collaboration leverages LTTS’ engineering expertise across 600+ major plants with Databricks’ AI and analytics platform to convert operational data into actionable Engineering Intelligence.The partnership will deliver solutions spanning Predictive Asset Reliability, Energy & Emissions Optimisation, Overall Equipment Effectiveness, Production and Quality Intelligence, and Sust..

Next Story
Infrastructure Urban

Opptra Partners with Unicommerce to Scale AI-Driven E-Commerce

Opptra, the AI-native e-commerce distributor founded by Flipkart co-founder Binny Bansal, has partnered with Unicommerce to enhance operations across India, the GCC, and Southeast Asia. The collaboration integrates Opptra’s brand expansion expertise with Unicommerce’s AI-led Uniware platform, enabling centralised management of orders, inventory, and fulfilment across warehouses, stores, and sales channels.Opptra retains full commercial ownership of online brand operations, from marketplace strategy and pricing to fulfilment and customer service. Leveraging Unicommerce’s 350+ integrations..

Next Story
Real Estate

AHS Properties Acquires Shangri-La Hotel for AED 1.1 Billion

AHS Properties has acquired the Shangri-La Hotel on Sheikh Zayed Road for AED 1.1 billion from Mismak Asset Management, marking one of the largest single-asset real estate deals in recent history. The 43-floor, 200-metre tower, completed in 2003, was among the first five-star hotels on the corridor.This acquisition complements AHS Tower and AHS City, forming a vertical corridor strategy that represents a substantial portion of the developer’s AED 50 billion year-end 2026 pipeline. Founder and CEO Abbas Sajwani described the purchase as a long-term investment in structurally constrained asset..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement